BP2 [Adjuvant]

Accession ARO:3007466
DefinitionBP2 is a novel beta-lactam-derived beta-lactamase inhibitor, efficacious when co-administered with meropenem in K. pneumoniae.
Classification5 ontology terms | Show
Parent Term(s)1 ontology terms | Show
Publications

Reddy N, et al. 2023. Antibiotics (Basel) 12(4): Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors. (PMID 37106995)